List of narcotics according to the Narcotics Act
The list of narcotics according to the Narcotics Act contains the substances of Annex I ( non- marketable narcotics , trade and sale prohibited; e.g. LSD ), Annex II ( marketable but non-prescription narcotics , trade permitted ) recorded in the German Narcotics Act (BtMG) as of July 2018 , Dispensing prohibited; such as raw materials such as coca leaves ) and Annex III ( marketable and prescription narcotics , dispensing according to BtMVV ; such as morphine ) to Section 1 (1) BtMG.
The basis for the traffic in narcotics are international agreements with the aim of combating the abuse of narcotic substances. Prescription narcotics may only be prescribed if their use is justified and the intended purpose cannot be achieved in any other way (see Section 13 (1) BtMG).
Tabular list
Column 1 contains the attachment number (I, II or III), so that the assignment of a substance can also be seen if it is sorted differently. Column 2 contains the international non-proprietary names (INN) assigned by the World Health Organization for the individual substances, column 3 lists other unprotected substance names such as short names or trivial names and column 4 contains the chemical substance names according to the nomenclature of the International Union of Pure and Applied Chemistry (IUPAC ).
| Contents : Appendix I - Appendix II - Appendix III |
| investment | International non-proprietary name | Other unprotected or common names | Chemical names ( IUPAC ) |
|---|---|---|---|
| Appendix I - Non-marketable narcotics | |||
| I. | Acetorphine | - | {4,5α-Epoxy-7α - [( R ) -2-hydroxypentan-2-yl] -6-methoxy-17-methyl-6,14-ethenomorphinan-3-yl} acetate |
| I. | - | Acetyldihydrocodeine | (4,5α-Epoxy-3-methoxy-17-methylmorphinan-6α-yl) acetate |
| I. | Acetylmethadol | - | (6-Dimethylamino-4,4-diphenyl-heptan-3-yl) acetate |
| I. | - | Acetyl-α-methylfentanyl | N -Phenyl- N - [1- (1-phenyl-propan-2-yl) -4-piperidyl] acetamide |
| I. | - | - | 4-allyloxy-3,5-dimethoxyphenethylazane |
| I. | Allylprodine | - | (3-Allyl-1-methyl-4-phenyl-4-piperidyl) propionate |
| I. | Alphacetylmethadol | - | [(3 R , 6 R ) -6-dimethylamino-4,4-diphenylheptan-3-yl] acetate |
| I. | Alphameprodin | - | [(3 RS , 4 SR ) -3-ethyl-1-methyl-4-phenyl-4-piperidyl] propionate |
| I. | Alphamethadol | - | (3 R , 6 R ) -6-Dimethylamino-4,4-diphenylheptan-3-ol |
| I. | Alphaprodin | - | [(3 RS , 4 SR ) -1,3-dimethyl-4-phenyl-4-piperidyl] propionate |
| I. | - | 5- (2-aminopropyl) indole (5-IT) | 1- (1 H -indol-5-yl) propan-2-amine |
| I. | Anileridine | - | Ethyl 1- [2- (4-aminophenyl) ethyl] -4-phenylpiperidine-4-carboxylate |
| I. | - | BDB | 1- (1,3-Benzodioxol-5-yl) butan-2-ylazane |
| I. | Benzethidine | - | Ethyl [1- (2-benzyloxy) ethyl] -4-phenyl-piperidine-4-carboxylate |
| I. | Benzfetamine | Benzphetamine | (Benzyl) (methyl) (1-phenylpropan-2-yl) azane |
| I. | - | MDPPP | 1- (1,3-Benzodioxol-5-yl) -2- (pyrrolidin-1-yl) propan-1-one |
| I. | - | Benzyl fentanyl | N - (1-Benzyl-4-piperidyl) - N -phenyl-propanamide |
| I. | - | Benzylmorphine | 3-Benzyloxy-4,5α-epoxy-17-methylmorphine-7-en-6α-ol |
| I. | Beta acetyl methadol | - | [(3 S , 6 R ) -6-dimethylamino-4,4-diphenylheptan-3-yl] acetate |
| I. | Betameprodine | - | [(3 RS , 4 RS ) -3-ethyl-1-methyl-4-phenyl-4-piperidyl] propionate |
| I. | Betamethadol | - | (3 S , 6 R ) -6-Dimethylamino-4,4-diphenylheptan-3-ol |
| I. | Betaprodine | - | [(3 RS , 4 RS ) -1,3-dimethyl-4-phenyl-4-piperidyl] propionate |
| I. | Bezitramide | - | 4- [4- (2-Oxo-3-propionyl-2,3-dihydrobenzimidazol-1-yl) piperidino] -2,2-diphenyl-butanenitrile |
| I. | - | 25B-NBOMe (2C-B-NBOMe) | 2- (4-Bromo-2,5-dimethoxyphenyl) - N - [(2-methoxyphenyl) methyl] ethanamine |
| I. | Brolamfetamine | Dimethoxybromoamfetamine (DOB) | ( RS ) -1- (4-Bromo-2,5-dimethoxyphenyl) propan-2-ylazane |
| I. | - | Bromodimethoxyphenethylamine (BDMPEA, 2C-B) | 4-bromo-2,5-dimethoxyphenethyl-azane |
| I. | - | Cannabis ( marijuana , plants and parts of plants belonging to the cannabis genus), with exceptions | - |
| I. | - | Cannabis resin ( hashish , the secreted resin of the plants belonging to the cannabis genus) | - |
| I. | Carfentanil | - | Methyl [1-phenethyl-4- ( N -phenyl-propanamido) piperidine-4-carboxylate] |
| I. | Cathinone | - | ( S ) -2-amino-1-phenylpropan-1-one |
| I. | - | 2C-C | 2- (4-chloro-2,5-dimethoxyphenyl) ethanamine |
| I. | - | 2C-D (2C-M) | 2- (2,5-dimethoxy-4-methylphenyl) ethanamine |
| I. | - | 2C-E | 2- (4-ethyl-2,5-dimethoxyphenyl) ethanamine |
| I. | - | 2C-l | 4-iodo-2,5-dimethoxyphenethyl-azane |
| I. | - | Clephedron (4-CMC, 4-chloromethcathinone) | 1- (4-chlorophenyl) -2- (methylamino) propan-1-one |
| I. | - | 6-Cl-MDMA | [1- (6-chloro-1,3-benzodioxol-5-yl) propan-2-yl] (methyl) azane |
| I. | Clonitacene | - | {2- [2- (4-chlorobenzyl) -5-nitrobenzimidazol-1-yl] ethyl} diethylazane |
| I. | - | 25C-NBOMe (2C-C-NBOMe) | 2- (4-chloro-2,5-dimethoxyphenyl) - N - [(2-methoxyphenyl) methyl] ethanamine |
| I. | - | Codeine N oxide | 4,5α-Epoxy-3-methoxy-17-methylmorphine-7-en-6α-ol-17-oxide |
| I. | Codoxime | - | (4,5α-Epoxy-3-methoxy-17-methylmorphinan-6-ylidene-aminooxy) acetic acid |
| I. | - | 2C-P | 2- (2,5-dimethoxy-4-propylphenyl) ethanamine |
| I. | - | 2C-T-2 | 4-ethylsulfanyl-2,5-dimethoxy-phenetylazane |
| I. | - | 2C-T-7 | 2,5-dimethoxy-4- (propylsulfanyl) phenethylazane |
| I. | Desomorphine | Dihydrodeoxymorphine | 4,5α-epoxy-17-methyl-morphinan-3-ol |
| I. | Diampromid | - | N - {2 - [(methyl) (phenetyl) amino] propyl} - N -phenylpropanamide |
| I. | - | Diethoxybromoamfetamine | 1- (4-Bromo-2,5-diethoxyphenyl) propan-2-ylazane |
| I. | Diethylthiamobutene | - | Diethyl (1-methyl-3,3-di-2-thienylallyl) azane |
| I. | - | N , N -Diethyltryptamine (Diethyltryptamine, DET) | Diethyl [2- (indol-3-yl) ethyl] azane |
| I. | - | Dihydroetorphine (18,19-dihydroetorphine) | (5 R , 6 R , 7 R , 14 R ) -4,5α-Epoxy-7α - [( R ) -2-hydroxypentan-2-yl] -6-methoxy-17-methyl-6,14-ethanomorphinan- 3-ol |
| I. | Dimenoxadol | - | (2-dimethylaminoethyl) [(ethoxy) (diphenyl) acetate] |
| I. | Dimepheptanol | Methadol | 6-dimethylamino-4,4-diphenyl-heptan-3-ol |
| I. | - | Dimethoxyamfetamine (DMA) | 1- (2,5-dimethoxyphenyl) propan-2-ylazane |
| I. | - | Dimethoxyethylamfetamine (DOET) | 1- (4-ethyl-2,5-dimethoxyphenyl) propan-2-ylazane |
| I. | - | Dimethoxymethamfetamine (DMMA) | 1- (3,4-Dimethoxyphenyl) - N -methylpropan-2-amine |
| I. | - | Dimethoxymethylamfetamine (DOM, STP) | ( RS ) -1- (2,5-dimethoxy-4-methylphenyl) propan-2-ylazane |
| I. | - | Dimethylheptyltetrahydrocannabinol (DMHP) | 6,6,9-Trimethyl-3- (3-methyl-octan-2-yl) -7,8,9,10-tetra-hydro-6 H -benzo (c) chromen-1-ol |
| I. | Dimethylthiamobutene | - | Dimethyl (1-methyl-3,3-di-2-thienylallyl) azane |
| I. | - | N , N -Dimethyltryptamine (Dimethyltryptamine, DMT) | [2- (indol-3-yl) ethyl] dimethyl-azane |
| I. | Dioxaphetyl butyrate | - | Ethyl (4-morpholino-2,2-diphenylbutanoate) |
| I. | Dipipanone | - | 4,4-diphenyl-6-piperidinoheptan-3-one |
| I. | - | DOC | 1- (4-chloro-2,5-dimethoxyphenyl) propan-2-ylazane |
| I. | Drotebanol | - | 3,4-dimethoxy-17-methyl-morphinan-6β, 14-diol |
| I. | - | N -Ethylbuphedrone (NEB) | 2- (ethylamino) -1-phenylbutan-1-one |
| I. | - | 4-ethyl methcathinone (4-EMC) | 1- (4-Ethylphenyl) -2- (methylamino) propan-1-one |
| I. | Ethylmethylthiamobutene | - | (Ethyl) (methyl) (1-methyl-3,3-di-2-thienylallyl) azane |
| I. | - | Ethylon (bk-MDEA, MDEC) | 1- (1,3-Benzodioxol-5-yl) -2- (ethylamino) propan-1-one |
| I. | - | Ethyl piperidyl benzilate | (1-ethyl-3-piperidyl) benzilate |
| I. | Eticyclidine | PCE | (Ethyl) (1-phenylcyclohexyl) azane |
| I. | Etonitaces | - | {2- [2- (4-ethoxybenzyl) -5-nitrobenzimidazol-1-yl] ethyl} diethylazane |
| I. | Etoxeridine | - | Ethyl {1- [2- (2-hydroxyethoxy) ethyl] -4-phenylpiperidine-4-carboxylate} |
| I. | Etryptamine | α-ethyltryptamine | 1- (Indol-3-yl) butan-2-ylazane |
| I. | - | FLEA | N - [1- (1,3-Benzodioxol-5-yl) propan-2-yl] - N -methyl-hydroxylamine |
| I. | - | 4-fluoroamfetamine (4-FA, 4-FMP) | ( RS ) -1- (4-fluorophenyl) propan-2-amine |
| I. | - | ρ-fluorofentanyl | N - (4-fluorophenyl) - N - (1-phenethyl-4-piperidyl) propanamide |
| I. | - | 2-fluoromethamfetamine (2-FMA) | 1- (2-fluorophenyl) - N -methylpropan-2-amine |
| I. | - | 3-fluoromethamfetamine (3-FMA) | 1- (3-fluorophenyl) - N -methylpropan-2-amine |
| I. | Furethidine | - | Ethyl [4-phenyl-1- (2-tetra-hydrofurfuryloxy) ethyl] piperidine-4-carboxylate |
| I. | - | Heroin (diacetylmorphine, diamorphine), with exceptions | [(5 R , 6 S ) -4,5-epoxy-17-methyl-morphine-7-en-3,6-diyl] diacetate |
| I. | Hydromorphinol | 14-hydroxydihydromorphine | 4,5α-epoxy-17-methyl-morphinan-3,6α, 14-triol |
| I. | - | N -hydroxyamfetamine (NOHA) | N - (1-phenylpropan-2-yl) hydroxylamine |
| I. | - | β-hydroxyfentanyl | N - [1- (2-Hydroxy-2-phenyl-ethyl) -4-piperidyl] - N -phenylpropanamide |
| I. | - | Hydroxymethylenedioxyamfetamine ( N -hydroxy-MDA, MDOH) | N - [1- (1,3-Benzodioxol-5-yl) propan-2-yl] hydroxylamine |
| I. | - | β-hydroxy-3-methyl-fentanyl ( ohmefentanyl ) | N - [1- (2-Hydroxy-2-phenyl-ethyl) -3-methyl-4-piperidyl] - N -phenylpropanamide |
| I. | Hydroxypethidine | - | Ethyl [4- (3-hydroxyphenyl) -1-methylpiperidine-4-carboxylate] |
| I. | - | 25I-NBOMe (2C-I-NBOMe) | 2- (4-iodo-2,5-dimethoxyphenyl) - N - [(2-methoxyphenyl) methyl] ethanamine |
| I. | Lefetamine | SPA | [( R ) -1,2-diphenylethyl] dimethylazane |
| I. | Levomethorphan | - | (9 R , 13 R , 14 R ) -3-methoxy-17-methylmorphinane |
| I. | Levophenacylmorphan | - | 2 - [(9 R , 13 R , 14 R ) -3-hydroxy-morphinan-17-yl] -1-phenyl-ethanone |
| I. | Lofentanil | - | Methyl [(3 R , 4 S ) -3-methyl-1-phenethyl-4- ( N -phenyl-propanamido) piperidine-4-carboxylate] |
| I. | Lysergide | N , N -diethyl-D-lysergamide (LSD, LSD-25) | N , N- Diethyl-6-methyl-9,10-didehydroergoline-8β-carboxamide |
| I. | - | TIMES | 3,5-dimethoxy-4- (2-methyl-allyloxy) phenethylazane |
| I. | - | MBDB | [1- (1,3-Benzodioxol-5-yl) butan-2-yl] (methyl) azane |
| I. | - | Mebroqualone | 3- (2-Bromophenyl) 2-methyl-quinazolin-4 (3H) -one |
| I. | Mecloqualone | - | 3- (2-Chlorophenyl) -2-methyl-quinazolin-4 (3H) -one |
| I. | - | Mescaline | 3,4,5-trimethoxyphenethylazane |
| I. | Metazocin | - | 3,6,11-trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol |
| I. | - | Methcathinone (ephedron) | 2-methylamino-1-phenylpropan-1-one |
| I. | - | Methiopropamine (MPA) | N -Methyl-1- (thiophen-2-yl) propan-2-amine |
| I. | - | Methoxetamine (MXE) | 2- (ethylamino) -2- (3-methoxyphenyl) cyclohexanone |
| I. | - | Methoxyamfetamine (PMA) | 1- (4-methoxyphenyl) propan-2-ylazane |
| I. | - | 5-methoxy- N , N -diisopropyltryptamine ( 5-MeO-DIPT ) | Diisopropyl [2- (5-methoxyindol-3-yl) ethyl] azane |
| I. | - | 5-methoxy-DMT ( 5-MeO-DMT ) | [2- (5-methoxyindol-3-yl) ethyl] dimethylazane |
| I. | - | - | (2-methoxyethyl) (1-phenyl-cyclohexyl) azane |
| I. | - | Methoxymetamfetamine (PMMA) | [1- (4-methoxyphenyl) propan-2-yl] (methyl) azane |
| I. | - | Methoxymethylenedioxyamfetamine (MMDA) | 1- (7-methoxy-1,3-benzodioxol-5-yl) propan-2-ylazane |
| I. | - | - | (3-methoxypropyl) (1-phenyl-cyclohexyl) azane |
| I. | - | Methylaminorex ( 4-methylaminorex ) | 4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-ylazane |
| I. | - | 4-methylbuphedrone (4-MeMABP) | 2- (methylamino) -1- (4-methylphenyl) butan-1-one |
| I. | Methyl desorphine | - | 4,5α-epoxy-6,17-dimethyl-morphine-6-en-3-ol |
| I. | Methyldihydromorphine | - | 4,5α-epoxy-6,17-dimethyl-morphinan-3,6α-diol |
| I. | - | Methylenedioxyethylamfetamine ( N -ethyl-MDA, MDE, MDEA) | [1- (1,3-Benzodioxol-5-yl) propan-2-yl] (ethyl) azane |
| I. | - | Methylenedioxymetamfetamine (MDMA) | [1- (1,3-Benzodioxol-5-yl) propan-2-yl] (methyl) azane |
| I. | - | α-methylfentanyl | N -Phenyl- N - [1- (1-phenylpropan-2-yl) -4-piperidyl] propanamide |
| I. | - | 3-methylfentanyl (mefentanyl) | N - (3-Methyl-1-phenethyl-4-piperidyl) - N -phenylpropanamide |
| I. | - | Methyl methaqualone | 3- (2,4-Dimethylphenyl) -2-methyl-quinazolin-4 (3H) one |
| I. | - | 3-methylmethcathinone (3-MMC) | 2- (methylamino) -1- (3-methylphenyl) propan-1-one |
| I. | - | 4-methylmethcathinone ( mephedrone ) | 1- (4-methylphenyl) -2-methylaminopropan-1-one |
| I. | - | Methylphenylpropionoxypiperidine ( MPPP ) | (1-methyl-4-phenyl-4-piperidyl) propionate |
| I. | - | Methyl-3-phenylpropylamine (1M-3PP) | (Methyl) (3-phenylpropyl) azane |
| I. | - | Methylphenyltetrahydropyridine ( MPTP ) | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| I. | - | Methyl piperidyl benzilate | (1-methyl-3-piperidyl) benzilate |
| I. | - | 4-methylthioamfetamine (4-MTA) | 1- [4- (methylsulfanyl) phenyl] propan-2-ylazane |
| I. | - | α-methylthiofentanyl | N -phenyl- N - {1- [1- (2-thienyl) propan-2-yl] -4-piperidyl} propanamide |
| I. | - | 3-methylthiofentanyl | N - {3-Methyl-1- [2- (2-thienyl) ethyl] -4-piperidyl} - N -phenyl-propanamide |
| I. | - | α-methyltryptamine (α-MT, AMT) | 1- (Indol-3-yl) propan-2-ylazane |
| I. | Metopon | 5-methyldihydromorphinone | 4,5α-epoxy-3-hydroxy-5,17-dimethylmorphinan-6-one |
| I. | Morphheridine | - | Ethyl (1- (2-morpholinoethyl) -4-phenylpiperidine-4-carboxylate) |
| I. | - | Morphine- N -oxide | (5 R , 6 S ) -4,5-epoxy-3,6-dihydroxy-17-methylmorphine-7-ene-17-oxide |
| I. | Myrophin | Myristyl benzyl morphine | (3-Benzyloxy-4,5α-epoxy-17-methylmorphin-7-en-6-yl) tetradecanoate |
| I. | - | 25 N -NBOMe (2C- N -NBOMe) | 2- (2,5-Dimethoxy-4-nitrophenyl) N - [(2-methoxyphenyl) methyl] ethanamine |
| I. | Nicomorphine | 3,6-dinicotinoylmorphine | 4,5α-Epoxy-17-methyl-morphine-7-en-3,6α-diyl-dinicotinate |
| I. | Noracymethadol | - | (6-methylamino-4,4-diphenyl-heptan-3-yl) acetate |
| I. | Norcodeine | N -desmethylcodeine | 4,5α-epoxy-3-methoxy-morphine-7-en-6α-ol |
| I. | Norlevorphanol | (-) 3-hydroxymorphinan | (9 R , 13 R , 14 R ) -Morphinan-3-ol |
| I. | Normorphine | Desmethylmorphine | 4,5α-epoxymorphine-7-en-3,6α-diol |
| I. | Norpipanon | - | 4,4-diphenyl-6-piperidinohexan-3-one |
| I. | - | Parahexyl | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6 H -benzo [c] chromen-1-ol |
| I. | - | PCPr | (1-phenylcyclohexyl) (propyl) azane |
| I. | - | Pentylon (bk-MBDP) | 1- (1,3-Benzodioxol-5-yl) -2- (methylamino) pentan-1-one |
| I. | Phenadoxone | - | 6-morpholino-4,4-diphenyl-heptan-3-one |
| I. | Phenampromide | - | N -Phenyl- N - (1-piperidinopropan-2-yl) propanamide |
| I. | Phenazocine | - | 6,11-Dimethyl-3-phenethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol |
| I. | Phencyclidine | PCP | 1- (1-phenylcyclohexyl) piperidine |
| I. | - | Phenethylphenylacetoxypipederidin (PEPAP) | (1-phenethyl-4-phenyl-4-piperidyl) acetate |
| I. | - | Phenethylphenyltetrahydropyridine (PEPTP) | 1-phenethyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| I. | Phenpromethamine | 1-methylamino-2-phenyl-propane (PPMA) | (Methyl) (2-phenylpropyl) azane |
| I. | Phenomorphan | - | 17-phenethylmorphinan-3-ol |
| I. | Phenoperidine | - | Ethyl [1- (3-hydroxy-3-phenyl-propyl) -4-phenylpiperidine-4-carboxylate] |
| I. | Piminodine | - | Ethyl [1- (3-anilinopropyl) -4-phenylpiperidine-4-carboxylate] |
| I. | - | PPP | 1-phenyl-2- (pyrrolidin-1-yl) propan-1-one |
| I. | Proheptazine | - | (1,3-Dimethyl-4-phenylazepan-4-yl) propionate |
| I. | Properidin | - | Isopropyl (1-methyl-4-phenyl-piperidine-4-carboxylate) |
| I. | - | Psilocin (psilotsin) | 3- (2-dimethylaminoethyl) indol-4-ol |
| I. | - | Psilocin- (eth) (4-Hydroxy-N, N-diethyltryptamine, 4-HO-DET) | 3- (2-Diethylaminoethyl) indol-4-ol |
| I. | Psilocybin | - | [3- (2-Dimethylaminoethyl) indol-4-yl] dihydrogen phosphate |
| I. | - | Psilocybin- (eth) | [3- (2-Diethylaminoethyl) indol-4-yl] dihydrogen phosphate |
| I. | - | 4-MePPP | 2- (pyrrolidin-1-yl) -1- (p-tolyl) propan-1-one |
| I. | Racemethorphan | - | (9 RS , 13 RS , 14 RS ) -3-methoxy-17-methylmorphinane |
| I. | Rolicyclidine | PHP (PCPy) | 1- (1-phenylcyclohexyl) pyrrolidine |
| I. | - | Salvia divinorum (plants and parts of plants) | - |
| I. | Tenamfetamine | Methylenedioxyamfetamine (MDA) | ( RS ) -1- (1,3-Benzodioxol-5-yl) propan-2-ylazane |
| I. | Tenocyclidine | TCP | 1- [1- (2-thienyl) cyclohexyl] piperidine |
| I. | - | Δ6a (10a) -Tetrahydrocannabinol (Δ6a (10a) -THC) | 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6 H -benzo [c] chromen-1-ol |
| I. | - | Δ6a-tetrahydrocannabinol (Δ6a-THC) | (9 R , 10a R ) -6,6,9-trimethyl-3-pentyl-8,9,10,10a-tetra-hydro-6 H -benzo [c] chromen-1-ol (6a R , 9 R , 10a R ) -6,6,9-trimethyl-3-pentyl-6a, 9,10,10a-tetrahydro-6 H -benzo [c] chromen-1-ol |
| I. | - | Δ7-tetrahydrocannabinol (Δ7-THC) | |
| I. | - | Δ8-tetrahydrocannabinol (Δ8-THC) | (6a R , 10a R ) -6,6,9-trimethyl-3-pentyl-6a, 7,10,10a-tetra-hydro-6 H -benzo [c] chromen-1-ol (6a R ) -6 , 6,9-trimethyl-3-pentyl-6a, 7,8,9-tetrahydro-6 H -benzo [c] chromen-1-ol |
| I. | - | Δ10-tetrahydrocannabinol (Δ10-THC) | |
| I. | - | Δ9 (11) -tetrahydrocannabinol (Δ9 (11) -THC) | (6a R , 10a R ) -6,6-dimethyl-9-methylene-3-pentyl-6a, 7,8,9,10,10a-hexahydro-6 H ol chromen-1-benzo [c] |
| I. | - | Thenyl fentanyl | N -Phenyl- N - (1-thenyl-4-piperidyl) propanamide |
| I. | - | Thienoamfetamine (thiopropamine) | 1- (Thiophen-2-yl) propan-2-amine |
| I. | - | Thiofentanyl | N -phenyl- N - {1- [2- (2-thienyl) ethyl] -4-piperidyl} propanamide |
| I. | Trimeperidine | - | (1,2,5-trimethyl-4-phenyl-4-piperidyl) propionate |
| I. | - | Trimethoxyamfetamine (TMA) | 1- (3,4,5-trimethoxyphenyl) propan-2-ylazane |
| I. | - | 2,4,5-trimethoxyamfetamine (TMA-2) | 1- (2,4,5-trimethoxyphenyl) propan-2-ylazane |
| Annex II - Marketable but not prescription narcotics | |||
| II | - | AB-CHMINACA | N - (1-Amino-3-methyl-1-oxobutan-2-yl) -1- (cyclohexylmethyl) -1 H -indazole-3-carboxamide |
| II | - | AB-FUBINACA | N - (1-Amino-3-methyl-1-oxobutan-2-yl) -1 - [(4-fluorophenyl) methyl] -1 H -indazole-3-carboxamide |
| II | - | AB-PINACA | N - (1-Amino-3-methyl-1-oxobutan-2-yl) -1-pentyl-1 H -indazole-3-carboxamide |
| II | - | Acetylfentanyl (desmethylfentanyl) | N -Phenyl- N - [1- (2-phenylethyl) piperidin-4-yl] acetamide |
| II | - | Acryloyl fentanyl (acrylic fentanyl, ACF) | N -Phenyl- N - [1- (2-phenylethyl) piperidin-4-yl] prop-3-enamide |
| II | - | 1-adamantyl (1-pentyl-1 H -indol-3-yl) methanone | (Adamantan-1-yl) (1-pentyl-1 H -indol-3-yl) methanone |
| II | - | ADB-CHMINACA (MAB-CHMINACA) | N - (1-Amino-3,3-dimethyl-1-oxobutan-2-yl) -1- (cyclohexylmethyl) -1 H -indazole-3-carboxamide |
| II | - | ADB-FUBINACA | N - (1-Amino-3,3-dimethyl-1-oxobutan-2-yl) -1 - [(4-fluorophenyl) methyl] -1 H -indazole-3-carboxamide |
| II | - | AH-7921 (doxylam) | 3,4-dichloro- N - {[1- (dimethylamino) cyclohexyl] methyl} benzamide |
| II | - | AKB-48 (APINACA) | N - (Adamantan-1-yl) -1-pentyl-1 H -indazole-3-carboxamide |
| II | - | AKB-48F | N - (Adamantan-1-yl) -1- (5-fluoropentyl) -1 H -indazole-3-carboxamide |
| II | - | α-PVT (α-PVT, α-pyrrolidinopentiothiophenone) | 2- (pyrrolidin-1-yl) -1- (thiophen-2-yl) pentan-1-one |
| II | - | AM-694 | [1- (5-fluoropentyl) -1 H -indol-3-yl] (2-iodophenyl) methanone |
| II | - | AM-1220 | {1 - [(1-methylpiperidin-2-yl) methyl] -1 H -indol-3-yl} (naphthalene-1-yl) -methanone |
| II | - | AM-1220-azepan | [1- (1-Methylazepan-3-yl) -1 H -indol-3-yl] (naphthalene-1-yl) -methanone |
| II | - | AM-2201 | [1- (5-fluoropentyl) -1 H -indol-3-yl] (naphthalene-1-yl) -methanone |
| II | - | AM-2232 | 5- [3- (Naphthalen-1-carbonyl) -1 H -indol-1-yl] pentanenitrile |
| II | - | AM-2233 | (2-iodophenyl) {1 - [(1-methylpiperidin-2-yl) methyl] -1 H -indol-3-yl} methanone |
| II | - | AMB-CHMICA (MMB-CHMICA) | Methyl {2- [1- (cyclohexylmethyl) -1 H -indole-3-carboxamido] -3-methylbutanoate} |
| II | - | AMB-FUBINACA (FUB-AMB) | Methyl (2- {1 - [(4-fluorophenyl) methyl] -1 H -indazole-3-carboxamide} -3-methylbutanoate) |
| II | Amfetaminil | - | (Phenyl) [(1-phenylpropan-2-yl) amino] acetonitrile |
| II | Amineptine | - | 7- (10,11-dihydro-5 H -dibenzo [a, d] [7] annulen-5-ylamino) heptanoic acid |
| II | Aminorex | - | 5-phenyl-4,5-dihydro-1,3-oxazol-2-ylazane |
| II | - | 5-APB | 1- (Benzofuran-5-yl) propan-2-amine |
| II | - | 6-APB | 1- (Benzofuran-6-yl) propan-2-amine |
| II | - | APICA (SDB-001, 2NE1) | N - (Adamantan-1-yl) -1-pentyl-1 H -indole-3-carboxamide |
| II | - | BB-22 (QUCHIC) | Quinolin-8-yl [1- (cyclohexylmethyl) -1 H -indole-3-carboxylate] |
| II | - | Benzylpiperazine (BZP) | 1-benzylpiperazine |
| II | - | Buphedron | 2- (methylamino) -1-phenylbutan-1-one |
| II | Butalbital | - | 5-allyl-5-isobutylbarbituric acid |
| II | - | Butobarbital | 5-butyl-5-ethylpyrimidine-2,4,6 (1H, 3H, 5H) -trione |
| II | - | Butylon | 1- (Benzo [d] [1,3] dioxol-5-yl) -2- (methylamino) butan-1-one |
| II | - | Butyrfentanyl (butyrylfentanyl) | N -phenyl- N - [1- (2-phenylethyl) piperidin-4-yl] butanamide |
| II | Cetobemidone | Ketobemidone | 1- [4- (3-Hydroxyphenyl) -1-methyl-4-piperidyl] propan-1-one |
| II | - | meta- chlorophenylpiperazine ( m-CPP ) | 1- (3-chlorophenyl) piperazine |
| II | - | 5Cl-AKB-48 (5C-AKB-48, AKB-48Cl, 5CI-APINACA, 5C-APINACA) | N - (Adamantan-1-yl) -1- (5-chloropentyl) -1 H -indazole-3-carboxamide |
| II | - | 5Cl-JWH-018 (JWH-018 N - (5-chloropentyl) analogue) | [1- (5-chloropentyl) -1 H -indol-3-yl] (naphthalene-1-yl) -methanone |
| II | - | d- cocaine | Methyl (3β- (benzoyloxy) tropane-2α-carboxylate) |
| II | - | CP 47,497 (cis -3- [4- (1,1-Dimethylheptyl) -2-hydroxyphenyl] -cyclohexanol) | 5- (1,1-Dimethylheptyl) -2 - [(1 RS , 3 SR ) -3-hydroxycyclohexyl] phenol |
| II | - | CP 47,497-C6 homolog ( cis -3- [4- (1,1-dimethylhexyl) -2-hydroxyphenyl] -cyclohexanol) | 5- (1,1-Dimethylhexyl) -2 - [(1 RS , 3 SR ) -3-hydroxycyclohexyl] phenol |
| II | - | CP 47,497-C8 homolog ( cis -3- [4- (1,1-dimethyloctyl) -2-hydroxyphenyl] -cyclohexanol) | 5- (1,1-Dimethyloctyl) -2 - [(1 RS , 3 SR ) -3-hydroxycyclohexyl] phenol |
| II | - | CP 47,497-C9 homolog ( cis -3- [4- (1,1-dimethylnonyl) -2-hydroxyphenyl] -cyclohexanol) | 5- (1,1-Dimethylnonyl) -2 - [(1 RS , 3 SR ) -3-hydroxycyclohexyl] phenol |
| II | - | CUMYL-PEGACLONE (SGT-151) | 5-pentyl-2- (2-phenylpropan-2-yl) -2,5-dihydro-1 H -pyrido [4,3-b] indol-1-one |
| II | - | CUMYL-4CN-BINACA (SGT-78) | 1- (4-Cyanobutyl) - N - (2-phenylpropan-2-yl) -1 H -indazole-3-carboxamide |
| II | - | CUMYL-5F-PEGACLONE (5F-Cumyl-PeGaClone, 5F-SGT-151) | 5- (5-fluoropentyl) -2- (2-phenylpropan-2-yl) -2,5-dihydro-1 H -pyrido [4,3-b] indol-1-on |
| II | - | CUMYL-5F-P7AICA (5-Fluoro-CUMYL-P7AICA, SGT-263) | 1- (5-fluoropentyl) - N - (2-phenylpropan-2-yl) -1 H -pyrrolo [2,3-b] pyridine-3-carboxamide |
| II | Cyclobarbital | - | 5- (Cyclohex-1-en-1-yl) -5-ethylpyrimidin-2,4,6 (1H, 3H, 5H) -trione |
| II | - | Cyclopropyl fentanyl | N -phenyl- N - [1- (2-phenylethyl) piperidin-4-yl] cyclopropanecarboxamide |
| II | - | Deoxypipradrol (2-DPMP) | 2- (diphenylmethyl) piperidine |
| II | - | Dextromethadone | ( S ) -6-Dimethylamino-4,4-diphenylheptan-3-one |
| II | Dextromoramide | - | ( S ) -3-Methyl-4-morpholino-2,2-diphenyl-1- (pyrrolidin-1-yl) butan-1-one |
| II | Dextropropoxyphene | - | [(2 S , 3 R ) -4-dimethylamino-3-methyl-1,2-diphenylbutan-2-yl] propionate |
| II | - | Diamorphine ; with limitation | [(5 R , 6 S ) -4,5-epoxy-17-methyl-morphine-7-en-3,6-diyl] diacetate |
| II | - | Diclazepam (2'-chlordiazepam) | 7-chloro-5- (2-chlorophenyl) -1-methyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| II | Difenoxin , with exceptions | - | 1- (3-cyano-3,3-diphenylpropyl) -4-phenylpiperidine-4-carboxylic acid |
| II | - | Dihydromorphine | 4,5α-epoxy-17-methylmorphinan-3,6α-diol |
| II | - | Dihydrothebaine | 4,5α-epoxy-3,6-dimethoxy-17-methylmorphine-6-en |
| II | - | Dimethocaine (DMC, Larocaine) | (3-Diethylamino-2,2-dimethylpropyl) -4-aminobenzoate |
| II | - | 2,5-dimethoxy-4-iodamfetamine (DOI) | 1- (4-iodo-2,5-dimethoxyphenyl) propan-2-amine |
| II | - | 3,4-dimethylmethcathinone (3,4-DMMC) | 1- (3,4-Dimethylphenyl) -2- (methylamino) propan-1-one |
| II | Diphenoxylate , with exceptions | - | Ethyl [1- (3-cyano-3,3-diphenylpropyl) -4-phenylpiperidine-4-carboxylate] |
| II | - | 4,4'-DMAR (para-methyl-4-methylaminorex) | 4-methyl-5- (4-methylphenyl) -4,5-dihydro-1,3-oxazol-2-amine |
| II | - | AM-2201 (5-fluoro-JWH-210) | (4-ethylnaphthalene-1-yl) [1- (5-fluoropentyl) -1 H -indol-3-yl] methanone |
| II | - | Ecgonine | 3β-hydroxytropane-2β-carboxylic acid |
| II | - | Erythroxylum coca (plants and parts of plants belonging to the species Erythroxylum coca - including the varieties bolivianum , spruceanum and novogranatense ) | - |
| II | - | Ethcathinone | ( RS ) -2- (ethylamino) -1-phenylpropan-1-one |
| II | Ethchlorvynol | - | 1-chloro-3-ethylpent-1-en-4-yn-3-ol |
| II | Ethinamate | - | (1-ethynylcyclohexyl) carbamate |
| II | - | 3- O -ethylmorphine ( ethylmorphine ), with exceptions | 4,5α-Epoxy-3-ethoxy-17-methylmorphine-7-en-6α-ol |
| II | - | Ethyl phenidate | Ethyl [2- (phenyl) -2- (piperidin-2-yl) acetate] |
| II | Etilamfetamine | N -ethylamphetamine | (Ethyl) (1-phenylpropan-2-yl) azane |
| II | - | 5F-ABICA (5F-AMBICA, 5-fluoro-ABICA, 5-fluoro-AMBICA) | N - (1-amino-3-methyl-1-oxobutan-2-yl) -1- (5-fluoropentyl) -1 H -indole-3-carboxamide |
| II | - | 5F-AB-PINACA (5-Fluor-AB-PINACA) | N - (1-Amino-3-methyl-1-oxobutan-2-yl) -1- (5-fluoropentyl) -1 H -indazole-3-carboxamide |
| II | - | 5F-ADB (5F-MDMB-PINACA) | Methyl {2- [1- (5-fluoropentyl) -1 H -indazole-3-carboxamide] -3,3-dimethylbutanoate} |
| II | - | 5F-AMB (5-fluoro-AMB) | Methyl {2- [1- (5-fluoropentyl) -1 H -indazole-3-carboxamido] -3-methylbutanoate} |
| II | - | FDU-PB-22 | Naphthalen-1-yl {1 [(4-fluorophenyl) methyl] -1 H -indole-3-carboxylate} |
| II | Fencamfamin | - | N -ethyl-3-phenylbicyclo [2.2.1] heptan-2-amine |
| II | - | Flephedron (4-fluoromethcathinone, 4-FMC) | 1- (4-fluorophenyl) -2- (methylamino) propan-1-one |
| II | - | Flubromazepam | 7-Bromo-5- (2-fluorophenyl) -1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| II | - | 4-fluoroisobutyrfentanyl (4-fluoroisobutyrylfentanyl, 4F-iBF, p-FIBF) |
N - (4-fluorophenyl) -2-methyl- N - [1-
(2-phenylethyl) piperidin-4-yl] propanamide |
| II | - | 4-fluoromethamfetamine (4-FMA) | 1- (4-fluorophenyl) - N -methylpropan-2-amine |
| II | - | 3-fluoromethcathinone (3-FMC) | 1- (3-fluorophenyl) -2- (methylamino) propan-1-one |
| II | - | 5-fluoropentyl-JWH-122 (MAM-2201) | [1- (5-fluoropentyl) -1 H -indol-3-yl] (4-methyl-naphthalen-1-yl) -methanone |
| II | - | p-fluorophenylpiperazine (p-FPP) | 1- (4-fluorophenyl) piperazine |
| II | - | 4-fluorotropacocaine | 3- (4-fluorobenzoyloxy) tropane |
| II | - | 5-fluoro-UR-144 (XLR-11) | [1- (5-fluoropentyl) -1 H -indol-3-yl] (2,2,3,3-tetramethylcyclopropyl) methanone |
| II | - | 5F-MN-18 (AM-2201 indazole carboxamide analog) | 1- (5-fluoropentyl) - N -1- (naphthalen-1-yl) -1 H -indazole-3-carboxamide |
| II | - | 5F-PB-22 (5F-QUPIC) | Quinolin-8-yl [1- (5-fluoropentyl) indole-3-carboxylate] |
| II | - | 5F-SDB-006 | N -Benzyl-1- (5-fluoropentyl) -1 H -indole-3-carboxamide |
| II | - | FUB-PB-22 | Quinolin-8-yl {1 - [(4-fluorophenyl) methyl] -1 H -indole-3-carboxylate} |
| II | - | Furanylfentanyl (FU-F) | N -phenyl- N - [1- (2-phenylethyl) piperidin-4-yl] furan-2-carboxamide |
| II | Glutethimide | - | 3-ethyl-3-phenylpiperidine-2,6-dione |
| II | - | Isocodeine | 4,5α-epoxy-3-methoxy-17-methylmorphine-7-en-6β-ol |
| II | Isomethadone | - | 6-dimethylamino-5-methyl-4,4-diphenylhexan-3-one |
| II | - | JWH-007 | (2-methyl-1-pentyl-1 H -indol-3-yl) (naphthalen-1-yl) methanone |
| II | - | JWH-015 | (2-methyl-1-propyl-1 H -indol-3-yl) (naphthalen-1-yl) -methanone |
| II | - | JWH-018 (1-pentyl-3- (1-naphthoyl) indole) | (Naphthalene-1-yl) (1-pentyl-1 H -indol-3-yl) methanone |
| II | - | JWH-019 (1-hexyl-3- (1-naphthoyl) indole) | (Naphthalene-1-yl) (1-hexyl-1 H -indol-3-yl) methanone |
| II | - | JWH-073 (1-butyl-3- (1-naphthoyl) indole) | (Naphthalene-1-yl) (1-butyl-1 H -indol-3-yl) methanone |
| II | - | JWH-081 | (4-methoxynaphthalene-1-yl) (1-pentyl-1 H -indol-3-yl) methanone |
| II | - | JWH-122 | (4-methylnaphthalene-1-yl) (1-pentyl-1 H -indol-3-yl) methanone |
| II | - | JWH-200 | [1- (2-morpholinoethyl) -1 H -indol-3-yl] (naphthalene-1-yl) -methanone |
| II | - | JWH-203 | 2- (2-chlorophenyl) -1- (1-pentyl-1 H -indol-3-yl) ethanone |
| II | - | JWH-210 | (4-ethylnaphthalene-1-yl) (1-pentyl-1 H -indol-3-yl) methanone |
| II | - | JWH-250 (1-pentyl-3- (2-methoxyphenylacetyl) indole) | 2- (2-methoxyphenyl) -1- (1-pentyl-1 H -indol-3-yl) ethanone |
| II | - | JWH-251 | 2- (2-methylphenyl) -1- (1-pentyl-1 H -indol-3-yl) ethanone |
| II | - | JWH-307 | [5- (2-fluorophenyl) -1-pentyl-1 H -pyrrole-3-yl] (naphthalene-1-yl) -methanone |
| II | Levamfetamine | Levamphetamine | ( R ) -1-phenylpropan-2-ylazane |
| II | - | Levmetamfetamine (levometamfetamine) | ( R ) - (methyl) (1-phenylpropan-2-yl) azane |
| II | Levomoramid | - | ( R ) -3-Methyl-4-morpholino-2,2-diphenyl-1- (pyrrolidin-1-yl) butan-1-one |
| II | Levorphanol | - | (9 R , 13 R , 14 R ) -17-methylmorphinan-3-ol |
| II | Mazindol | - | 5- (4-chlorophenyl) -2,5-dihydro-3H-imidazolo [2,1-a] isoindol-5-ol |
| II | - | MDMB-CHMCZCA (EGMB-CHMINACA) | Methyl {2- [9- (cyclohexylmethyl) -9 H -carbazole-3-carboxamido] -3,3-dimethylbutanoate} |
| II | - | MDMB-CHMICA | Methyl {2- [1- (cyclohexylmethyl) -1H-indole-3-carboxamido] -3,3-dimethylbutanoate} |
| II | Mefenorex | - | 3-chloro- N - (1-phenylpropan-2-yl) propan-1-amine |
| II | Meprobamate | - | (2-methyl-2-propylpropane-1,3-diyl) dicarbamate |
| II | Mesocarb | - | (Phenylcarbamoyl) [3- (1-phenylpropan-2-yl) -1,2,3-oxadiazol-3-ium-5-yl] azanide |
| II | Metamfetamine | Methamphetamine | (2 S ) - N -Methyl-1-phenylpropan-2-amine |
| II | ( RS ) - metamfetamine | Metamfetamine racemate | ( RS ) - (methyl) (1-phenylpropan-2-yl) azane |
| II | - | Methadone intermediate (premethadone) | 4-dimethylamino-2,2-diphenylpentanenitrile |
| II | Methaqualone | - | 2-methyl-3- (2-methylphenyl) quinazolin-4 (3H) -one |
| II | - | Methoxyacetyl fentanyl | 2- methoxy- N -phenyl- N - [1- (2-phenylethyl)
piperidin-4-yl] acetamide |
| II | - | Methedrone (4-methoxymethcathinone, PMMC) | 1- (4-methoxyphenyl) -2- (methylamino) propan-1-one |
| II | - | p-methoxyethylamfetamine (PMEA) | N -ethyl-1- (4-methoxyphenyl) propan-2-amine |
| II | - | 3-methoxyphencyclidine (3-MeO-PCP) | 1- [1- (3-methoxyphenyl) cyclohexyl] piperidine |
| II | - | 4-methylamfetamine | 1- (4-methylphenyl) propan-2-amine |
| II | - | Methylbenzylpiperazine (MBZP) | 1-benzyl-4-methylpiperazine |
| II | - | 3,4-methylenedioxypyrovalerone (MDPV) | 1- (Benzo [d] [1,3] dioxol-5-yl) -2- (pyrrolidin-1-yl) pentan-1-one |
| II | - | 4-methylethcathinone (4-MEC) | 2- (ethylamino) -1- (4-methylphenyl) propan-1-one |
| II | - | Methylone (3,4-methylenedioxy- N -methcathinone, MDMC) | 1- (Benzo [d] [1,3] dioxol-5-yl) -2- (methylamino) propan-1-one |
| II | ( RS , SR ) - methylphenidate | - | Methyl [( RS , SR ) (phenyl) (2-piperidyl) acetate] |
| II | Methyprylon | - | 3,3-Diethyl-5-methylpiperidine-2,4-dione |
| II | - | MMB-2201 (5F-AMB-PICA, 5F-MMB-PICA) | Methyl {2- [1- (5-fluoropentyl) -1 H -indole-3-carboxamido] -3-methylbutanoate} |
| II | - | Poppy straw concentrate (the material obtained during the processing of plants and parts of plants of the species Papaver somniferum to concentrate the alkaloids) | - |
| II | - | Moramid intermediate product (premoramid) | 3-methyl-4-morpholino-2,2-diphenylbutanoic acid |
| II | - | MT-45 | 1-Cyclohexyl-4- (1,2-diphenylethyl) piperazine |
| II | - | Naphyrone (naphthylpyrovalerone) | 1- (Naphthalen-2-yl) -2- (pyrrolidin-1-yl) pentan-1-one |
| II | - | NE-CHMIMO (JWH-018 N - (Cyclohexylmethyl) analog) | [1- (Cyclohexylmethyl) -1 H -indol-3-yl] (naphthalen-1-yl) methanone |
| II | Nicocodine | 6-nicotinoyl codeine | (4,5α-Epoxy-3-methoxy-17-methylmorphine-7-en-6α-yl) nicotinate |
| II | Nicodicodine | 6-nicotinoyl dihydrocodeine | (4,5α-Epoxy-3-methoxy-17-methylmorphinan-6α-yl) nicotinate |
| II | - | Oripavin | 4,5α-epoxy-6-methoxy-17-methylmorphina-6,8-dien-3-ol |
| II | - | NM-2201 (CBL-2201) | Naphthalen-1-yl [1- (5-fluoropentyl) -1H-indole-3-carboxylate] |
| II | - | Ocfentanil (A-3217) |
N - (2-fluorophenyl) -2-methoxy- N - [1-
(2-phenylethyl) piperidin-4-yl] acetamide |
| II | Oxymorphone | 14-hydroxydihydromorphinone | 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one |
| II | - | Papaver bracteatum (plants and parts of plants, with the exception of the seeds ofplants belongingto the species Papaver bracteatum ), with exceptions | - |
| II | - | PB-22 (QUPIC) | Quinolin-8-yl (1-pentylindole-3-carboxylate) |
| II | - | Pentedrone | 2- (methylamino) -1-phenylpentan-1-one |
| II | - | Pethidine intermediate A (prepethidine) | 1-methyl-4-phenylpiperidine-4-carbonitrile |
| II | - | Pethidine intermediate B (norpethidine) | Ethyl (4-phenylpiperidine-4-carboxylate) |
| II | - | Pethidine intermediate C (pethidic acid) | 1-methyl-4-phenylpiperidine-4-carboxylic acid |
| II | Phendimetrazine | - | (2 S , 3 S ) -3,4-dimethyl-2-phenylmorpholine |
| II | Phenmetrazine | - | 3-methyl-2-phenylmorpholine |
| II | Pholcodine , with exceptions | Morpholinyl ethyl morphine | 4,5α-epoxy-17-methyl-3- (2-morpholinoethoxy) morphine-7-en-6α-ol |
| II | Propiram | - | N - (1-piperidinopropan-2-yl) - N - (2-pyridyl) propanamide |
| II | Pyrovalerone | - | 2- (pyrrolidin-1-yl) -1- (ρ-tolyl) pentan-1-one |
| II | - | α-pyrrolidinovalerophenone (α-PVP) | 1-phenyl-2- (pyrrolidin-1-yl) pentan-1-one |
| II | Racemoramide | - | ( RS ) -3-methyl-4-morpholino-2,2-diphenyl-1- (pyrrolidin-1-yl) butan-1-one |
| II | Racemorphan | - | (9 RS , 13 RS , 14 RS ) -17-methylmorphinan-3-ol |
| II | - | RCS-4 | (4-methoxyphenyl) (1-pentyl-1 H -indol-3-yl) methanone |
| II | - | RCS-4 ortho isomer (o-RCS-4) | (2-methoxyphenyl) (1-pentyl-1H-indol-3-yl) methanone |
| II | - | SDB-006 | N -Benzyl-1-pentyl-1 H -indole-3-carboxamide |
| II | Secbutabarbital | Butabarbital | 5- (Butan-2-yl) -5-ethylpyrimidin-2,4,6 (1H, 3H, 5H) -trione |
| II | - | STS-135 (5F-2NE1) | N - (Adamantan-1-yl) -1- (5-fluoropentyl) -1H-indole-3-carboxamide |
| II | - | Δ9-tetrahydrocannabinol (Δ9-THC) | 6,6,9-trimethyl-3-pentyl-6a, 7,8,10a-tetrahydro-6 H -benzo [c] chromene-1-ol |
| II | - | Tetrahydrofuranylfentanyl (THF-F) | N -Phenyl- N - [1- (2-phenylethyl) piperidin-4-yl] tetrahydrofuran-2-carboxamide |
| II | - | Tetrahydrothebaine | 4,5α-epoxy-3,6-dimethoxy-17-methylmorphinan |
| II | Thebacon | Acetyldihydrocodeinone | (4,5α-Epoxy-3-methoxy-17-methylmorphin-6-en-6-yl) acetate |
| II | - | Thebaine | 4,5α-epoxy-3,6-dimethoxy-17-methylmorphina-6,8-diene |
| II | - | THJ-018 (JWH-018 indazole analog) | (Naphthalene-1-yl) (1-pentyl-1 H -indazole-3-yl) -methanone |
| II | - | THJ-2201 (AM-2201 indazole analogue) | [1- (5-fluoropentyl) -1 H -indazol-3-yl] (naphthalen-1-yl) methanone |
| II | cis - tilidine | - | Ethyl [(1 RS , 2 RS ) -2-dimethylamino-1-phenylcyclohex-3-enecarboxylate] |
| II | - | 3-trifluoromethylphenylpiperazine (TFMPP) | 1- [3- (trifluoromethyl) phenyl] piperazine |
| II | - | U-47700 | 3,4-dichloro- N - [2- (dimethylamino) cyclohexyl] - N -methylbenzamide |
| II | - | U-48800 | 2- (2,4-dichlorophenyl) - N - [2- (dimethylamino) cyclohexyl] - N -methylacetamide |
| II | - | UR-144 | (1-pentyl-1 H -indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone |
| II | Vinyl bit | - | 5-ethenyl-5- (pentan-2-yl) pyrimidin-2,4,6 (1H, 3H, 5H) -trione |
| II | Zipeprol | - | 1-methoxy-3- [4- (2-methoxy-2-phenylethyl) piperazin-1-yl] -1-phenylpropan-2-ol |
| Appendix III - Marketable and prescription drugs | |||
| III | Alfentanil | - | N - {1- [2- (4-ethyl-5-oxo-4,5-dihydro-1 H -tetrazol-1-yl) ethyl] -4-methoxymethyl-4-piperidyl} - N -phenylpropanamid |
| III | Allobarbital | - | 5,5-diallyl barbituric acid |
| III | Alprazolam , with exceptions | - | 8-Chloro-1-methyl-6-phenyl-4 H - [1,2,4] triazolo [4,3-a] [1,4] benzodiazepine |
| III | Amfepramon , with exceptions | Diethyl propion | 2-diethylamino-1-phenylpropan-1-one |
| III | Amphetamine | amphetamine | ( RS ) -1-phenylpropan-2-ylazane |
| III | Amobarbital | - | 5-ethyl-5-isopentylbarbituric acid |
| III | Barbital , with exceptions | - | 5,5-diethylbarbituric acid |
| III | Bromazepam , with exceptions | - | 7-Bromo-5- (2-pyridyl) -1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Brotizolam , with exceptions | - | 2-Bromo-4- (2-chlorophenyl) -9-methyl-6 H -thieno [3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepine |
| III | Buprenorphine | - | (5 R , 6 R , 7 R , 14 S ) -17-Cyclopropyl-methyl-4,5-epoxy-7 - [( S ) -2-hydroxy-3,3-dimethylbutan-2-yl] -6- methoxy-6,14-ethanomorphinan-3-ol |
| III | Camazepam | - | (7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1 H -1,4-enzodiazepin-3-yl) (dimethyl carbamate) |
| III | - | Cannabis (marijuana, plants and parts of plants belonging to the cannabis genus); with limitation | - |
| III | Cathine , with exceptions | (+) - norpseudoephedrine (D-norpseudoephedrine) | (1 S , 2 S ) -2-amino-1-phenylpropan-1-ol |
| III | Chlordiazepoxide , with exceptions | - | 7-chloro-2-methylamino-5-phenyl-3 H -1,4-benzodiazepine-4-oxide |
| III | Clobazam , with exceptions | - | 7-chloro-1-methyl-5-phenyl-1,3-dihydro-2 H -1,5-benzodiazepine-2,4 (5H) -dione |
| III | Clonazepam , with exceptions | - | 5- (2-chlorophenyl) -7-nitro-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Clorazepate , with exceptions | - | ( RS ) -7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1 H -1,4-benzodiazepine-3-carboxylic acid |
| III | Clotiazepam , with exceptions | - | 5- (2-Chlorophenyl) -7-ethyl-1-methyl-1,3-dihydro-2 H -thieno [2,3-e] [1,4] diazepin-2-one |
| III | - | Cocaine (benzoylecgonine methyl ester) | Methyl [3β- (benzoyloxy) tropane-2β-carboxylate] |
| III | - | Codeine (3-methylmorphine), with exceptions | 4,5α-epoxy-3-methoxy-17-methylmorphine-7-en-6α-ol |
| III | Delorazepam | - | 7-chloro-5- (2-chlorophenyl) -1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Dexamfetamine | Dexamphetamine | ( S ) -1-phenylpropan-2-ylazane |
| III | Dexmethylphenidate | - | Methyl [( R , R ) (phenyl) (2-piperidyl) acetate] |
| III | - | Diamorphine ; with limitation | [(5 R , 6 S ) -4,5-epoxy-17-methyl-morphine-7-en-3,6-diyl] diacetate |
| III | Diazepam , with exceptions | - | 7-chloro-1-methyl-5-phenyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Dihydrocodeine , with exceptions | - | 4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol |
| III | Dronabinol | - | (6a R , 10a R ) -6,6,9-trimethyl-3-pentyl-6a, 7,8,10a-tetrahydro-6 H -benzo [c] chromen-1-ol |
| III | Estazolam , with exceptions | - | 8-Chloro-6-phenyl-4 H - [1,2,4] triazolo [4,3-a] benzodiazepine |
| III | Ethylloflazepat | - | Ethyl [7-chloro-5- (2-fluorophenyl) -2-oxo-2,3-dihydro-1 H -1,4-benzodiazepine-3-carboxylate] |
| III | Etizolam | - | 4- (2-Chlorophenyl) -2-ethyl-9-methyl-6 H -thieno [3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepine |
| III | Etorphine | - | (5 R , 6 R , 7 R , 14 R ) -4,5-epoxy-7 - [( R ) -2-hydroxypentan-2-yl] -6-methoxy-17-methyl-6,14-ethenomorphinan- 3-ol |
| III | Fenetylline | - | 1,3-Dimethyl-7- [2- (1-phenyl-propan-2-ylamino) ethyl] -3,7-dihydro-2 H -purine-2,6 (1H) -dione |
| III | Fenproporex , with exceptions | - | ( RS ) -3- (1-Phenylpropan-2-ylamino) propanenitrile |
| III | Fentanyl | - | N - (1-Phenethyl-4-piperidyl) - N -phenylpropanamide |
| III | Fludiazepam | - | 7-chloro-5- (2-fluorophenyl) -1-methyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Flunitrazepam | - | 5- (2-fluorophenyl) -1-methyl-7-nitro-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Flurazepam , with exceptions | - | 7-chloro-1- (2-diethylaminoethyl) -5- (2-fluorophenyl) -1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Halazepam , with exceptions | - | 7-chloro-5-phenyl-1- (2,2,2-trifluoroethyl) -1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Haloxazolam | - | 10-Bromo-11b- (2-fluorophenyl) -2,3,7,11b-tetrahydro [1,3] oxazolo [3,2-d] [1,4] benzodiazepin-6 (5H) -one |
| III | Hydrocodone | Dihydrocodeinone | 4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one |
| III | Hydromorphone | Dihydromorphinone | 4,5α-epoxy-3-hydroxy-17-methylmorphinan-6-one |
| III | - | γ-Hydroxybutyric acid (GHB), with exceptions | 4-hydroxybutanoic acid |
| III | Ketazolam , with exceptions | - | 11-chloro-2,8-dimethyl-12b-phenyl-8,12b-dihydro-4 H - [1,3] oxazino [3,2-d] [1,4] benzodiazepine-4,7 (6H) - dion |
| III | Levacetylmethadol | Levomethadyl Acetate (LAAM) | [(3 S , 6 S ) -6-dimethylamino-4,4-diphenylheptan-3-yl] acetate |
| III | Levomethadone | - | ( R ) -6-Dimethylamino-4,4-diphenylheptan-3-one |
| III | Lisdexamfetamine | - | (2 S ) -2,6-diamino- N - [(2 S ) -1-phenylpropan-2-yl] hexanamide |
| III | Loprazolam , with exceptions | - | 6- (2-Chlorophenyl) -2 - [(Z) -4-methylpiperazin-1-ylmethylene] -8-nitro-2,4-dihydro-1 H -imidazo [1,2-a] [1,4] benzodiazepin-1-one |
| III | Lorazepam , with exceptions | - | ( RS ) -7-chloro-5- (2-chlorophenyl) -3-hydroxy-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Lormetazepam , with exceptions | - | 7-chloro-5- (2-chlorophenyl) -3-hydroxy-1-methyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Medazepam , with exceptions | - | 7-chloro-1-methyl-5-phenyl-2,3-dihydro-1 H -1,4-benzodiazepine |
| III | Methadone | - | ( RS ) -6-Dimethylamino-4,4-diphenylheptan-3-one |
| III | Methylphenidate | - | Methyl [( RS ; RS ) (phenyl) (2-piperidyl) acetate] |
| III | Methylphenobarbital , with exceptions | Mephobarbital | ( RS ) -5-ethyl-1-methyl-5-phenyl-barbituric acid |
| III | Midazolam , with exceptions | - | 8-chloro-6- (2-fluorophenyl) -1-methyl-4 H -imidazo [1,5-a] [1,4] benzodiazepine |
| III | - | Morphine | (5 R , 6 S ) -4,5-epoxy-17-methyl-morphine-7-en-3,6-diol |
| III | Nabilone | - | (6a RS , 10a RS ) -1-Hydroxy-6,6-dimethyl-3- (2-methyloctan-2-yl) -6,6a, 7,8,10,10a-hexahydro-9 H -benzo [c ] chrome-9-one |
| III | Nimetazepam | - | 1-methyl-7-nitro-5-phenyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Nitrazepam , with exceptions | - | 7-nitro-5-phenyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | North Azepam , with exceptions | - | 7-chloro-5-phenyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Normethadone | - | 6-dimethylamino-4,4-diphenyl-hexan-3-one |
| III | - | Opium (the coagulated sap of the plants belonging to the species Papaver somniferum ), with exceptions | - |
| III | Oxazepam , with exceptions | - | 7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-2 H -1,4-benzo-diazepin-2-one |
| III | Oxazolam , with exceptions | - | (2 RS , 11b SR ) -10-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro [1,3] oxazolo [3,2-d] [1,4] benzodiazepine-6 (5H) -one |
| III | Oxycodone | 14-hydroxydihydrocodeinone | 4,5α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one |
| III | - | Papaver somniferum (plants and parts of plants, with the exception of the seeds, ofplants belongingto the species Papaver somniferum including the subspecies setigerum ), with exceptions | - |
| III | Pemoline , with exceptions | - | 2-imino-5-phenyl-1,3-oxazolidin-4-one |
| III | Pentazocine | - | (2 R , 6 R , 11 R ) -6,11-Dimethyl-3- (3-methylbut-2-en-1-yl) -1,2,3,4,5,6-hexahydro-2,6 -methano-3-benzazocin-8-ol |
| III | Pentobarbital | - | ( RS ) -5-ethyl-5- (pentan-2-yl) barbituric acid |
| III | Pethidine | - | Ethyl (1-methyl-4-phenyl-piperidine-4-carboxylate) |
| III | - | Phenazepam | 7-Bromo-5- (2-chlorophenyl) -1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Phenobarbital , with exceptions | - | 5-ethyl-5-phenylbarbituric acid |
| III | Phentermine , with exceptions | - | 2-benzylpropan-2-ylazane |
| III | Pinazepam | - | 7-chloro-5-phenyl-1- (prop-2-in-1-yl) -1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Pipradrol | - | Diphenyl (2-piperidyl) methanol |
| III | Piritramide | - | 1 '- (3-cyano-3,3-diphenylpropyl) [1,4'-bipiperidine] -4'-carboxamide |
| III | Prazepam , with exceptions | - | 7-chloro-1-cyclopropylmethyl-5-phenyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Remifentanil | - | Methyl {3- [4-methoxycarbonyl-4- ( N -phenylpropanamido) piperidino] propanoate} |
| III | Secobarbital | - | 5-allyl-5- (pentan-2-yl) barbituric acid |
| III | Sufentanil | - | N - {4-methoxymethyl-1- [2- (2-thienyl) ethyl] -4-piperidyl} - N -phenylpropanamide |
| III | Tapentadol | - | 3 - [(2 R , 3 R ) -1-dimethylamino-2-methylpentan-3-yl] phenol |
| III | Temazepam , with exceptions | - | ( RS ) -7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Tetrazepam , with exceptions | - | 7-chloro-5- (cyclohex-1-enyl) -1-methyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one |
| III | Tilidine , with exceptions | trans -tilidine | Ethyl [(1 RS , 2 SR ) -2-dimethyl-amino-1-phenylcyclohex-3-enecarboxylate] |
| III | Triazolam , with exceptions | - | 8-Chloro-6- (2-chlorophenyl) -1-methyl-4 H - [1,2,4] triazolo [4,3-a] [1,4] benzodiazepine |
| III | Zolpidem | - | N , N -Dimethyl-2- [6-methyl-2- (p-toly) imidazo [1,2-a] pyridin-3-yl] acetamide |
Extensions, exceptions and restrictions to the substances mentioned in the list
-
↑ Annex I also applies to:
- the esters, ethers and molecular compounds of the substances listed in this annex, if they are not listed in another annex and the existence of such esters, ethers and molecular compounds is possible;
- the salts of the substances listed in this Annex, if the existence of such salts is possible;
- The preparations of the substances listed in this Annex, if they are not
a) used exclusively for diagnostic or analytical purposes without being used on or in the human or animal body and their content of one or more narcotics does not exceed 0.001 percent or the substances isotope-modified in the preparations or
b) are particularly excluded;
- the stereoisomers of the substances listed in this or any other annex, if they are to be misused as narcotics;
- Substances according to § 2 paragraph 1 number 1 letters b to d with substances listed in this or another annex as well as the biological materials suitable for the reproduction or extraction of substances according to § 2 paragraph 1 number 1 letters b to d, if misuse for intoxication purposes is provided. -
↑ except:
a) their seeds, unless they are intended for unauthorized cultivation,
b) if they come from cultivation in countries of the European Union with certified seeds of varieties that were approved on March 15 of the cultivation year in the article 9 of the delegates Regulation (EU) No. 639/2014 of the Commission of March 11, 2014 supplementing Regulation (EU) No. 1307/2013 of the European Parliament and of the Council with provisions on direct payments to owners of agricultural holdings within the framework of support schemes of the Common Agricultural Policy and amending Annex X of the above-mentioned ordinance (OJ L 181 of June 20, 2014, p. 1) are listed in the currently applicable version of the common catalog of varieties for agricultural plant species, or their tetrahydrocannabinol content does not exceed 0.2 percent and traffic with them (with the exception of cultivation) serves exclusively commercial or scientific purposes, which exclude abuse for intoxication purposes n,
c) if they are planted as protective strips during beet cultivation and destroyed before flowering,
d) if they are cultivated by agricultural companies that meet the requirements of Section 1 (4) of the Farmers Pension Fund Act, with the exception of Companies involved in forestry, horticulture and viticulture, fish farming, pond farming, beekeeping, inland fisheries and migrant sheep farming, or those who are eligible for aid under Regulation (EU) No. 1307/2013 of the European Parliament and of the Council of 17 December 2013 with provisions on direct payments to owners of agricultural holdings within the framework of support schemes of the common agricultural policy and repealing Council Regulation (EC) No. 637/2008 and Council Regulation (EC) No. 73/2009 (OJ. L 347 of December 20, 2013, p. 608) in the currently applicable version and the cultivation takes place exclusively from certified seeds of varieties that are listed on March 15 of the cultivation year in the article 9 of the Delegated Regulation (EU) No. 639/2014 listed common catalog of varieties for agricultural plant species (industrial hemp) or
e) for the purposes specified in Annex III - ↑ except for diamorphine for the purposes specified in Annexes II and III
-
↑ Annex II also applies to:
- the esters, ethers and molecular compounds of the substances listed in this Annex as well as the esters and ethers of the substances listed in Annex III, with the exception of gamma-hydroxybutyric acid (GHB), if they are not listed in another Annex and that Existence of such esters, ethers and molecular compounds is possible;
- the salts of the substances listed in this Annex, if the existence of such salts is possible, as well as the salts and molecular compounds of the substances listed in Annex III, if the existence of such salts and molecular compounds is possible and they are not used by a doctor, dentist or veterinarian;
- the preparations of the substances listed in this annex, if they are not
a) used exclusively for diagnostic or analytical purposes without being used on or in the human or animal body and their content of one or more narcotics, lyophilisates and mixtures of substances to be used in of the ready-to-use solution does not exceed 0.01 percent in each case or the substances in the preparations are isotope-modified or
b) are specifically excluded. - ↑ if it is intended for the manufacture of preparations for medical purposes
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 0.5 mg difenoxine, calculated as a base, and, based on this amount, at least 5 percent of atropine sulfate per divided form
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 0.25 per cent or, per divided form, up to 2.5 mg diphenoxylate, calculated as base, and, based on these quantities, at least 1 per cent atropine sulfate contain
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 2.5 percent or, per divided form, up to 100 mg of ethyl morphine, calculated as base
- ↑ except for decorative purposes
- ↑ except in preparations that contain up to 0.15 per cent as a solution without another substance from Annexes I to III, but not more than 150 mg per packaging unit, or up to 20 mg pholcodine, calculated as base, per divided form
-
↑ Annex III also applies to:
- the salts and molecular compounds of the substances listed in this Annex, if they are used by a doctor, dentist or veterinarian according to the knowledge of medical science;
- the preparations of the substances listed in this annex, if they are not
a) used exclusively for diagnostic or analytical purposes without being used on or in the human or animal body and their content of one or more narcotics, lyophilisates and the corresponding mixtures of substances to be used in of the ready-to-use solution does not exceed 0.01 percent in each case or the substances in the preparations are isotope-modified or
b) are specifically excluded. For exempt preparations - apart from those with codeine or dihydrocodeine - the narcotics regulations on import, export and transit apply. Preparations exempted according to letter b of the item Barbital can, however, be imported, exported or carried out without authorization in accordance with Section 11 of the Narcotics Act if, under the circumstances, improper use is not to be expected. - ↑ except in preparations which contain up to 1 mg alprazolam per divided form without any other substance from Annexes I to III
- ↑ except in preparations without delayed release of active ingredients, which without another substance from Annexes I to III up to 22 mg per divided form, and in preparations with delayed release of active substance, which without another substance from Annexes I to III up to 64 mg per divided form Amfepramon, calculated as base, included
-
↑ except in preparations which
a) without another substance from Annexes I to III up to 10 percent or
b) without being used on or in the human or animal body, serve exclusively diagnostic or analytical purposes and without another substance from the Annexes I to III per package unit contain no more than 25 g barbital, calculated as acid - ↑ except in preparations that contain up to 6 mg bromazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations that contain up to 0.02 per cent or up to 0.25 mg of brotizolam per divided form without another substance from Annexes I to III
- ↑ only from a cultivation that is carried out for medical purposes under state control in accordance with Articles 23 and 28 paragraph 1 of the 1961 Uniform Convention on Narcotic Drugs, as well as in preparations that are approved as finished medicinal products
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 5 percent as a solution, but not more than 1600 mg per packaging unit or per divided form up to 40 mg cathine, calculated as base
- ↑ except in preparations that contain up to 25 mg of chlordiazepoxide per divided form without another substance from Annexes I to III
- ↑ except in preparations which contain up to 30 mg clobazam per divided form without another substance from Annexes I to III
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 0.25 percent as a drop solution, but not more than 250 mg per packaging unit or up to 2 mg clonazepam per divided form
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 50 mg per divided form, as dry substance only for parenteral use up to 100 mg, chlorazepate as dipotassium salt
- ↑ except in preparations that contain up to 20 mg clotiazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 2.5 percent or, per divided form, up to 100 mg codeine, calculated as base. For exempt preparations that are prescribed for people dependent on narcotics or alcohol, the regulations on prescribing and dispensing narcotic drugs apply.
- ↑ only in preparations that are approved for substitution treatment
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 1 percent as syrup or drip solution, but not more than 250 mg per packaging unit, or up to 10 mg diazepam per divided form
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 2.5 per cent or, per divided form, up to 100 mg of dihydrocodeine, calculated as base. For exempt preparations that are prescribed for people dependent on narcotics or alcohol, the regulations on prescribing and dispensing narcotic drugs apply.
- ↑ except in preparations that contain up to 2 mg estazolam per divided form without another substance from Annexes I to III
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 11 mg Fenproporex, calculated as a base, per divided form
- ↑ except in preparations that contain up to 30 mg flurazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 120 mg halazepam per divided form
- ↑ except in preparations for injection which, without another substance from Annexes I to III, contain up to 20 percent and per divided form up to 2 g γ-hydroxybutyric acid, calculated as acid
- ↑ except in preparations that contain up to 45 mg ketazolam per divided form without another substance from Annexes I to III
- ↑ except in preparations which contain up to 2.5 mg loprazolam per divided form without another substance from Annexes I to III
- ↑ except in preparations that contain up to 2.5 mg lorazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations that contain up to 2 mg lormetazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations that contain up to 10 mg medazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 200 mg methylphenobarbital, calculated as acid, per divided form
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 0.2 percent or up to 15 mg of midazolam for each divided form
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 0.5 percent as a drip solution per divided form, but not more than 250 mg per packaging unit, or up to 10 mg nitrazepam per divided form
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 0.5 per cent as a drip solution per divided form, but not more than 150 mg per packaging unit, or up to 15 mg of nordazepam per divided form
- ↑ except in preparations that are manufactured using a process technology described in the homeopathic section of the pharmacopoeia, if the final concentration does not exceed the sixth decimal power
- ↑ except in preparations which contain up to 50 mg oxazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations which contain up to 20 mg oxazolam per divided form without another substance from Annexes I to III
-
↑ - except if the intercourse with them (with the exception of cultivation) is for ornamental purposes and if their morphine content does not exceed 0.02 percent when dry; In this case, the narcotics regulations apply to the import, export and transit
- except in preparations that are manufactured according to a process technology described in the homeopathic part of the pharmacopoeia, if the final concentration does not exceed the fourth decimal power
- except in preparations that are without contain another substance from Annexes I to III up to 0.015 percent morphine, calculated as a base, and which are composed of one or more other components in such a way that the narcotic cannot be used by easily applicable procedures or to an extent that is dangerous to public health can be recovered - ↑ except in preparations which, without another substance from Annexes I to III, contain up to 20 mg pemoline, calculated as a base, per divided form
- ↑ except in preparations which, without any other substance from Annexes I to III, contain up to 10 percent or, per divided form, up to 300 mg phenobarbital, calculated as acid
- ↑ except in preparations which, without another substance from Annexes I to III, contain up to 15 mg phentermine, calculated as a base, per divided form
- ↑ except in preparations that contain up to 20 mg of prazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations that contain up to 20 mg temazepam per divided form without another substance from Annexes I to III
- ↑ except in preparations that contain up to 100 mg tetrazepam per divided form without another substance from Annexes I to III
- ↑ except in solid preparations with delayed release of active ingredients which, without another substance from Annexes I to III, contain up to 300 mg of tilidine per divided form, calculated as base, and, based on this amount, at least 7.5 percent of naloxone hydrochloride
- ↑ except in preparations that contain up to 0.25 mg triazolam per divided form without another substance from Annexes I to III
